MedTrace Logo

ICIS in Burn Patients Compared to Other Inflammatory Markers

NCT04894500 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 97

Last updated 2026-01-07

No results posted yet for this study

Summary

The current markers of inflammation that govern antibiotic treatment have their significant limitations, especially in patients with burns. According to previously published data, the newly proposed marker of infectious inflammation, the Intensive Care Infection Score (ICIS), appears to be a suitable diagnostic tool in distinguishing between inflammation of infectious and non-infectious origin in these patients. The other advantage is its low price.

This study aims to compare ICIS with other used indicators of inflammation in patients with burns both children and adults.

Conditions

Interventions

DIAGNOSTIC_TEST

Flow fluorescence cytometry

Level of inflammatory markers in body fluid samples

Sponsors & Collaborators

  • Charles University, Czech Republic

    lead OTHER

Principal Investigators

  • Helena Lahoda Brodská, MD, PhD · Ústav lékařské biochemie a laboratorní diagnostiky 1. LF UK a Všeobecné fakultní nemocnice Praha

Eligibility

Min Age
6 Months
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2024-06-30
Completion
2024-10-31

Countries

  • Czechia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04894500 on ClinicalTrials.gov